Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/57779
Full metadata record
DC FieldValueLanguage
dc.creatorAngélica Nogueira Rodriguespt_BR
dc.date.accessioned2023-08-11T22:21:21Z-
dc.date.available2023-08-11T22:21:21Z-
dc.date.issued2019-05-17-
dc.citation.volume1pt_BR
dc.citation.spagee45pt_BR
dc.citation.epagee52pt_BR
dc.identifier.doi10.1200/EDBK_249695pt_BR
dc.identifier.issn1548-8748pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/57779-
dc.description.resumoHPV vaccine programs in Latin America run the risk of repeating the problems associated with Papanicolaou(Pap) test programs, an efficient, life-saving tool that is unfortunately underutilized for cancer prevention, inlow- and middle-income countries. There is a great need for vigilance in the ongoing implementation of the HPV vaccine in Latin Americapt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofAmerican Society of Clinical Oncology Educational Book-
dc.rightsAcesso Abertopt_BR
dc.subjectVaccinationpt_BR
dc.subjectHPVpt_BR
dc.subjectLatin Americapt_BR
dc.subjectPapanicolaou Testpt_BR
dc.subject.otherVacinaçãopt_BR
dc.subject.otherPapillomavirus Humanopt_BR
dc.subject.otherAmérica Latinapt_BR
dc.subject.otherTeste de Papanicolaoupt_BR
dc.titleHPV Vaccination in Latin America: Global Challenges and Feasible Solutionspt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://ascopubs.org/doi/full/10.1200/EDBK_249695pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
HPV Vaccination in Latin America Global pdfa.pdf2.1 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.